J. Goldman & CO LP PROGENICS PHARMACEUTICALS IN Call Options Transaction History

J. Goldman & CO LP

  • $3.21 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2019

Feb 14, 2020
SELL
N/A
-211,100 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
N/A
11,100 Added 5.55%
211,100 $1.07 Million
Q2 2019

Aug 14, 2019
BUY
N/A
200,000 New
200,000 $1.23 Million
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email